In this week’s issue:
Announcement:
- Please see the attached email from the Office of the Vice-President Research & International – a second call for nominations for the UBC Faculty Research Awards. Faculty of Medicine signature deadlines will be as follows:
o UBC Killam Faculty Research Fellowship – September 10, 2014
o President’s Award for Public Education through Media – September 10, 2014
o UBC Killam Faculty Research Prize – September 26, 2014
o Jacob Biely Faculty Research Prize – October 9, 2014
o Charles A. McDowell Award for Excellence in Research – October 9, 2014
- Please see the second attached email from the Office of the Vice-President Research & International with details on the VPRI Office’s Award Document Library.
- CIHR has recently announced a number of new funding opportunities, including:
o Catalyst Grant: HIV/AIDS Community-Based Research (Fall 2014 Competition)
o Fellowship: 2014-2015
o New Investigator Salary Award: 2014-2015
Please view the full list of current funding opportunities on the CIHR website.
Funding Opportunities:
- BrightFocus Foundation – Alzheimer’s Disease Research (reminder)
- Progeria Research Foundation – Applications for Grants (reminder)
- Michael J. Fox Foundation for Parkinson’s Research – Target Pipeline Program (reminder)
- BrightFocus Foundation – National Glaucoma Research (reminder)
Events:
- Centre for Blood Research Postdoc Seminar Series – Leaky pipes and urine trouble: the role of podocalyxin in vascular and kidney barrier functions
FUNDING OPPORTUNITIES:
BrightFocus Foundation – Alzheimer’s Disease Research
Deadline: October 14, 2014
BrightFocus provides research funds for U.S. domestic as well as international researchers pursuing pioneering research leading to a greater understanding of Alzheimer’s disease.
The maximum award value of the ADR Standard Award is US $250,000, payable over three years.
Interested post doctoral researchers should apply for the ADR Research Fellowship, a two year award with a maximum value of US $100,000.
All submitted proposals are subjected to peer-review by a qualified Scientific Review Committee, consisting of active academic and clinical researchers from within the Alzheimer’s disease research field.
Preference is made for exciting, cutting-edge type projects that would not, at their present stage, be competitive for large government or industry awards. Typically these awards are made to junior investigators, or to more established investigators who are proposing particularly innovative research.
Visit the BrightFocus Foundation website for eligibility and application guidelines.
Progeria Research Foundation – Applications for Grants
Deadline: October 27, 2014
The Progeria Research Foundation has brought progeria to the forefront of research efforts, engaging large, reputable institutions such as the National Institutes of Health and Children’s Hospital Boston to invest their resources in Hutchinson-Gilford Progeria Syndrome.
The foundation currently is accepting applications for awards in three categories: Innovator Awards, Established Investigator Awards, and Specialty Awards.
1) Innovator Awards: Two-year grants of up to $150,000 will be awarded to an investigator to embark on new lines of investigation, and to produce enough preliminary data to be competitive for longer-term funding by NIH and/or other agencies.
2) Established Investigator Awards: Grants of up to $300,000 over three years will be awarded to senior investigators established either in the field of progeria or a field that can be directly applied to progeria.
3) Specialty Awards: Grants of up to $50,000 will be awarded to support smaller, more technology-driven projects, including sequencing, screening potential drugs, obtaining cell lines (including IPSCs), and preparation of antibodies. Funding amounts and lengths are flexible.
To be eligible, principal investigators must hold a postdoctoral position or beyond. Grants will be awarded only to applicants affiliated with institutions with 501(c)(3) status or the equivalent (for foreign institutions).
Visit the Progeria Research Foundation website for complete program guidelines, information about previous grant recipients, and application instructions.
Michael J. Fox Foundation for Parkinson’s Research – Target Pipeline Program
Deadline: October 29, 2014
The Michael J. Fox Foundation for Parkinson’s Research, which seeks to stimulate development of Parkinson’s disease therapeutics, is accepting pre-proposals for the spring cycle of its Target Validation program.
Part of the foundation’s annual Edmond J. Safra Core Programs for PD Research, the Target Validation program supports work seeking to determine whether manipulating a novel biological target has impact in a Parkinson’s disease-relevant animal model — an essential early step to the development of potentially promising therapies.
The program supports two-year grants of up to $250,000. Total annual direct costs cannot exceed $100,000, and no more than 2 percent (academic institutions) or 10 percent (for-profit organizations) may go to indirect costs.
Eligible applicants include biotechnology/pharmaceutical companies, other for-profit entities, public and private nonprofit universities, colleges, hospitals, laboratories, and government agencies.
As therapeutic programs may require many kinds of expertise, MJFF encourages industry and academic collaborations when appropriate. Given the significant coordination and leadership necessary for the program, postdoctoral fellows are not eligible to apply as principal investigators.
For consideration, pre-proposals must be received no later than October 29, 2014. Upon review, selected applicants will be invited to submit full proposals by November 19.
An informational conference call will be held for applicants on September 19, 2014. (An RSVP is required.)
Visit the MJFF website for complete program guidelines, an FAQ, application procedures, and to RSVP for the conference call.
BrightFocus Foundation – National Glaucoma Research
Deadline: November 4, 2014
BrightFocus provides research funds for U.S. domestic as well as international researchers pursuing pioneering research with relevance to the prevention and treatment of glaucoma.
The maximum award value of the NGR Standard Award is US $100,000, payable over two years.
Preference is made for exciting, cutting-edge type projects that would not, at their present stage, be competitive for large government or industry awards. Typically these awards are made to junior investigators, or to more established investigators who are proposing particularly innovative research.
Visit the BrightFocus Foundation website for eligibility and application guidelines.
EVENTS:
Centre for Blood Research Postdoc Seminar Series – Leaky pipes and urine trouble: the role of podocalyxin in vascular and kidney barrier functions
Date & Time: August 6, 2014, 12-1pm
Location: LSC 3, Life Sciences Centre, 2350 Health Sciences Mall, Vancouver
Seminar by:
Dr. Michael Hughes
Postdoctoral Research Fellow
Biomedical Research Centre, UBC